Varenicline 1mg BID

DRUG3 trials

Sponsors

Pfizer, Centre for Addiction and Mental Health, Yale University

Conditions

E-cigarette UseNicotine DependenceNicotine Use DisorderSmoking CessationSubstance Use DisordersTobacco SmokingTobacco Use DisorderVaping

Phase 2

A Trial of Varenicline for E-cigarette Cessation

RecruitingNCT07040566

Yale UniversityE-cigarette Use, Nicotine Dependence, Vaping

Start: 2025-10-14End: 2030-10-30Target: 326Updated: 2025-12-17

Phase 4

Smoking Cessation Study In Healthy Adolescent Smokers

CompletedNCT01312909

PfizerSmoking Cessation

Start: 2011-04-30End: 2018-01-31Updated: 2018-08-09

tDCS Plus Varenicline for Smoking Cessation

RecruitingNCT06798324

Centre for Addiction and Mental HealthNicotine Dependence, Nicotine Use Disorder, Smoking Cessation +3

Start: 2025-03-10End: 2028-08-01Target: 160Updated: 2025-08-12

Related Papers

High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial.

2020-09-2520 citations

Reduction in Central Venous Catheter Occlusions: Impact of a Pressure Activated Anti-reflux Connector With a Vascular Access Nurse Algorithm in Assessing Occluded Catheters

Journal of the Association for Vascular Access2016-11-302 citations